Lactiga Announces NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment

Press/Media

Period14 Oct 2020

Media coverage

1

Media coverage

  • TitleLactiga Announces NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment
    Media name/outletFirstWord Pharma
    Country/TerritoryUnited States
    Date14/10/20
    URLwww.firstwordpharma.com/node/1765380
    PersonsRebecca Powell